Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure

Editor's Notes

  • #6 Concept of strain imaging
  • #10 6 month rehospitalisation 42% , death 38% @ 6months - vellore heart failure registry
  • #52 Stress on ARNi therapy nTproBNP measurement Effect on obesity
  • #53 Breathing Not Properly trial – BNP evidence : value of 100 ADHF PRIDE : nt proBNP -900; ICON : age stratification <300 excludes ADHF
  • #54 Arrythmia- decompensation
  • #71 Iron = AFFIRM HF trial : Functional iron deficiency ( TSAT 25%Ferritin < 100) : Better outcomes after iv iron supplementation. 500–1000 mg of iron in patients who have a hemoglobin <10 with iron deficiency.
  • #75 5 HR reduce All cause mortality by 18 %= Can add Ivabradine
  • #76 Data from Ephesus trial showed :
  • #81 DECLARE TIMI58 trial : 1st showed reduced hospitalizations for HF, reduced CV death triggered DAPA HF trial
  • #83 Reverse Remodelling.
  • #87 EMPEROR-REDUCED TRIAL: Substantial benefit after days of randomisation